Urinary incontinence neuromod newcomer Amber Therapeutics nets $100M
The University of Oxford spinout's series A round follows up on positive preliminary data from a first-in-human trial earlier this year.
Stay updated with breaking news from Lightstone Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The University of Oxford spinout's series A round follows up on positive preliminary data from a first-in-human trial earlier this year.
Dublin-based FIRE1 today announced that the first Irish patient has been successfully implanted with its FIRE1 System for remote heart failure monitoring. The innovative system has the potential to positively
Reprieve Cardiovascular, a pioneer in personalized fluid management for acute decompensated heart failure (ADHF) emerges from stealth launching with $42M in Series A financing round.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
When we first wrote about the Patent Eligibility Restoration Act, I had no idea I would have the honor of being invited to testify before the Subcommittee on Intellectual Property of the Senate Judiciary Committee...